Guide
Senolytics and cellular aging, explained simply
Senolytics target senescent cells, a real aging-biology area.
In plain English
Senolytics target aging biology that scientists take seriously, but many consumer claims are still early.
Plain-English pages for the questions people usually ask first.
Guide
Senolytics target senescent cells, a real aging-biology area.
Mechanism
Senescent cells have stopped dividing and can release inflammatory signals.
Mechanism
Senolytics are proposed interventions that selectively remove some senescent cells.
Question
Fisetin is discussed as a senolytic, but robust proof that it clears senescent cells in humans and improves meaningful outcomes is not established.
Question
Dasatinib plus quercetin is a research senolytic combination, not a self-directed longevity routine.
Mechanism
Autophagy is a cellular recycling process.
We ask a simple question first: how close is this claim to proof in real people?
Human evidence and accepted medical use for the specific purpose.
Some human data or strong early evidence, with important questions still open.
Interesting science, but not proof it works in people.
People talk about it, but reliable evidence is weak.
The main story is approval status, legality, quality or risk.
Mechanism
AMPK is an energy-sensing pathway involved in metabolism.
Guide
Senescent cells are part of aging biology, but they are not simply bad cells to eliminate everywhere.
Guide
Senolytics are interventions intended to remove certain senescent cells, but most longevity claims remain early.
No source updates in this lane yet.
No. Senescence has useful roles in wound healing and cancer suppression, so context and selectivity matter.
One plain-English email on the claims, studies and regulatory updates worth knowing - without protocols, hype or miracle claims.
No protocols. No miracle claims. No spam.